An important issue that currently attracts attention in pharmaceutical packaging is how to reduce accidents caused by children's exposure to drugs or misuse of drugs. Statistics show that 30% of child deaths in many countries are caused by mistakenly ingested drugs. There are even a lot of governments even more legislation to control all blister-packaged drugs, because the packaging of such drugs is similar to the packaging of soft sweets and other sweets.

At present, my country's pharmaceutical packaging materials still have some problems such as inconvenience to take out, insufficient stability of pharmaceutical ingredients, and lack of customized packaging for children. This year, the State Food and Drug Administration revised the management measures for pharmaceutical packaging materials, with the purpose of improving the safety standards of pharmaceutical packaging materials for blister machines. The new standard will replace the past multi-level standards of countries, industries and enterprises, and put forward higher requirements in terms of product material, shape and stability. The drug regulatory department will also regularly inspect the impact of the packaging materials of the blister machine on the quality of drugs, formulate a catalog of qualified products, and publish unqualified products.

With the in-depth implementation of GMP certification in our country, the requirements for the pharmaceutical packaging industry will be increasingly strict. The pharmaceutical packaging of the blister machine will gradually achieve standardization, meticulousness, and serialization, and the continuous progress of new materials, new technologies and new processes , Which will make the packaging of medicines more convenient, safer and more in line with environmental protection requirements. It is comprehensive, practical, and anti-counterfeiting is an inevitable trend in the development of pharmaceutical packaging, and it also conforms to the needs of national policies and regulations and market development.